PAR
Click for more information
5.77% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4234

  1. Denial
    9,832 Posts.
    lightbulb Created with Sketch. 1250
    clock Created with Sketch.
    17/07/24
    17:10
    Post #: 74798817
    Yes and I'm wondering if 404 days in fact effectively solves for DMOAD labelling (and pricing).

    Let's hope this is confirmed as this should finally open the floodgates and have MP commit.
    PAR Price at posting: 30.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Major high-grade gold discovery at Claw Project – promising results revealed!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS High-grade niobium extended across multiple targets
right-arrow Created with Sketch.
NEWS Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢ 		Change
-0.015(5.77%) 		Mkt cap ! $85.80M
Open High Low Value Volume
28.0¢ 29.0¢ 24.0¢ $969.3K 3.648M

Buyers (Bids)

No. Vol. Price($)
6 34182 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 24689 1
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.